BENEDETTI, LUANA
 Distribuzione geografica
Continente #
EU - Europa 2.677
NA - Nord America 1.032
AS - Asia 695
Continente sconosciuto - Info sul continente non disponibili 128
SA - Sud America 64
AF - Africa 14
OC - Oceania 2
Totale 4.612
Nazione #
IT - Italia 2.599
US - Stati Uniti d'America 969
SG - Singapore 254
CN - Cina 147
VN - Vietnam 132
BD - Bangladesh 57
HK - Hong Kong 40
BR - Brasile 34
CA - Canada 28
FR - Francia 23
JP - Giappone 13
MX - Messico 11
AR - Argentina 10
DE - Germania 9
JM - Giamaica 8
EC - Ecuador 7
FI - Finlandia 7
ID - Indonesia 7
IN - India 7
IQ - Iraq 6
PL - Polonia 6
CO - Colombia 5
NL - Olanda 5
PH - Filippine 5
PK - Pakistan 5
GB - Regno Unito 4
AZ - Azerbaigian 3
CL - Cile 3
CR - Costa Rica 3
HN - Honduras 3
KE - Kenya 3
MA - Marocco 3
RO - Romania 3
SV - El Salvador 3
TR - Turchia 3
UA - Ucraina 3
AT - Austria 2
AU - Australia 2
BZ - Belize 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
IE - Irlanda 2
IR - Iran 2
MD - Moldavia 2
MY - Malesia 2
NI - Nicaragua 2
SA - Arabia Saudita 2
SC - Seychelles 2
TW - Taiwan 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
MT - Malta 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
RU - Federazione Russa 1
SE - Svezia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.484
Città #
Genoa 1.554
Vado Ligure 372
Genova 357
Rapallo 177
Singapore 136
San Jose 133
Ashburn 52
Ho Chi Minh City 44
Hong Kong 36
Beijing 27
New York 26
Hanoi 23
Santa Clara 23
Lauterbourg 21
Milan 21
Los Angeles 19
Bordighera 18
Council Bluffs 17
Phoenix 16
Rome 13
Tokyo 13
Boardman 12
Houston 12
St Louis 12
Buffalo 11
Dallas 10
Atlanta 7
Chicago 7
Kingston 7
Denver 6
Frankfurt am Main 6
Helsinki 6
Louisville 6
Mexico City 6
Milwaukee 6
Biên Hòa 5
Florence 5
Haiphong 5
Philadelphia 5
Savona 5
Brooklyn 4
Da Nang 4
Karachi 4
Minneapolis 4
Toronto 4
Verona 4
Warsaw 4
Washington 4
Baku 3
Beloit 3
Brentwood 3
Buenos Aires 3
Chula Vista 3
Des Moines 3
Elk Grove Village 3
Hays 3
Jacksonville 3
Miami 3
Montreal 3
Nairobi 3
Oklahoma City 3
Orem 3
Orlando 3
Pittsburgh 3
San Antonio 3
San Salvador 3
Seattle 3
Tampa 3
The Bronx 3
Vancouver 3
Abidjan 2
Albenga 2
Albuquerque 2
Athens 2
Bari 2
Belize City 2
Bogotá 2
Bologna 2
Bình Dương 2
Bắc Ninh 2
Carcare 2
Castel Boglione 2
Cincinnati 2
City of London 2
Concord 2
Corona 2
Defiance 2
Detroit 2
Dhaka 2
Dublin 2
Edgewater 2
Edgewood 2
Erbil 2
Figino 2
Fort Wayne 2
Gary 2
Gilroy 2
Grand Rapids 2
Guayaquil 2
Herriman 2
Totale 3.395
Nome #
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 355
Dysimmune mononeuropathies: A diagnosis not to be missed 241
FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative Analysis 157
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 155
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. 140
Regional variation of Guillain-Barré syndrome 137
COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series 135
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 133
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 131
NERVE ULTRASOUND AND 3-TESLA MAGNETIC RESONANCE IMAGING FINDINGS IN NODO-PARANODOPATHIES: CORRELATION WITH CLINICAL AND NEUROPHYSIOLOGICAL EXAMINATIONS 130
FDG-PET and ASL MRI identify largely overlapping hypermetabolic and hyperperfusion changes in limbic autoimmune encephalitis 128
An aggressive form of MOGAD treated with aHSCT: A case report 126
High-resolution ultrasound and superb microvascular imaging findings in a case of post-COVID-19 vaccine parsonage-turner syndrome with multiple nerves involvement 122
ATYPICAL STIFF PERSON SYNDROME WITH ANTI-IGLON5 ANTIBODIES: A CASE REPORT 120
WHAT MAINTENANCE THERAPY TO PERFORM IN PATIENTS WITH ANTI-MAG NEUROPATHY AFTER THE FIRST CYCLE OF RITUXIMAB? A COMPARISON BETWEEN TWO REGIMENS 116
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 111
N-methyl-D-aspartate receptor antibody-related pathologies and pre-existent mental state disorders 107
DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS 106
I can’t count, but I can beat you playing cards: a case report on autoimmune encephalitis 100
Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments 96
Are basketball players more likely to develop Hirayama disease? 95
Impact of environmental factors and physical activity on disability and quality of life in CIDP 94
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies 91
Incident anti-LGI1 autoimmune encephalitis during dementia with Lewy bodies: when Occam razor is a double-edged sword 90
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease 90
Imaging for inflammatory neuropathies. 87
Anti-LGI1 encephalitis and Langerhans cell histiocytosis: two associated entities? A case report 87
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 85
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 79
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy 78
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis 75
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 75
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score 73
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 66
Patient With Rigidity and Fasciculations 63
Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory 62
Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses 61
Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis 55
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome 51
Improving laboratory diagnostics in myasthenia gravis 50
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 49
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 49
null 48
null 41
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. 38
Cervical alterations in Hirayama disease: an MRI and FDG-PET combined approach 17
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 17
Totale 4.612
Categoria #
all - tutte 16.252
article - articoli 16.252
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.504


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022137 0 0 0 4 9 12 11 29 22 18 6 26
2022/2023207 15 24 3 26 11 37 2 15 39 4 29 2
2023/2024313 13 14 23 66 12 58 22 26 10 13 15 41
2024/20251.129 61 61 25 93 107 91 90 196 71 65 148 121
2025/20262.184 265 56 105 124 261 86 235 108 161 188 488 107
2026/2027388 179 116 93 0 0 0 0 0 0 0 0 0
Totale 4.612